Introduction
Conventional ventilators used in intensive care usually have a closed system with viral filters on gas intake and exhaust ports, which together with closed suction systems, reduce to a minimum the venting of unfiltered and potentially infectious expiratory gases to the immediate environment.
The practice of non-invasive ventilation (NIV) has resulted in the development of ventilators that are designed as semiopen systems with high gas flows vented through a small orifice or orifices immediately next to the patient. This results in up to 20 litres per minute of fresh and expired gas, together with water droplets contaminated with patient secretions, being released into the atmosphere surrounding the patient, and adjacent to staff and other patients.
While there is little evidence to determine the risk to other patients and healthcare workers by these nebulised respiratory tract secretions, it may be significant. Acinetobacter can cause cross-infection by airborne spread, 1 Staphylococcus aureus can be dispersed by common colds and sneezing, 2 and we have cultured methicillin-resistant Staphylococcus aureus (MRSA) on agar plates held in front of the expiratory orifice of these ventilators. The initial advice during the severe acute respiratory syndrome (SARS) outbreak was that NIV should not be used, and the British Thoracic Society guidelines recommend that aerosol-generating procedures, including NIV and continuous positive airway pressure (CPAP), should be avoided. 3 In-line heat and moisture exchange (HME) viral filters have been used in an attempt to prevent pathogens being nebulised in the expiratory gases, but these add to the weight of the circuit and cannot be used with other forms of humidification, which are usually used in these high-flow circuits.
Description
We have devised a simple change to the expiratory orifice which allows all the gas escaping through it to be ducted away from the patient. Instead of the manufacturer' s 3 mm circular orifice on the outer surface of a tube (Figure 1 and 2) , a blank has been fixed across the side arm of a 'T' piece (Armstrong Medical Ltd.) through which a 3 mm hole has been drilled (Figure 3 ). Tubing may be attached to this side arm (Figure 4) and then connected to an anaesthetic gas scavenging unit or to a viral filter, preferably with an in-line water trap to prevent water-logging of the filter.
Performance and results
Modifying such a device may result in an alteration of its
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performance as well as affecting the manufacturer' s warranty and liability. We have tested this modification against the manufacturer' s original device using a BiPAP Vision (Respironics Inc.) ventilator connected to a test lung. The two orifices were tested by measuring volumes delivered to the test lung, using a pneumotachograph at different inspiratory positive airway pressures (IPAP) up to a peak airway pressure of 32 cm H 2 O and at three levels of expiratory positive airway pressure (EPAP): 5, 10 and 15 cm of H 2 O ( Table 1) .
At EPAP of 5 cm H 2 O the mean difference was 0.04 litres/ minute (standard deviation (SD) 0.15 L/min, 95% confidence interval (CI) between -0.06 and +0.15 L/min) (Figure 5 ). At EPAP of 10 cm H 2 O the mean difference was 0.16 L/min (SD 0.10 L/min, 95% CI 0.08-0.23 L/min) (Figure 6 ). At EPAP of 15 cm H 2 O, the mean difference was 0.14 L/min (SD 0.08 L/min, 95% CI 0.06-0.21 L/min) (Figure 7 ). There were no leaks in the system other than the two expiratory devices on test.
Discussion
For many years the part played by ventilators and associated tubing in nosocomial and cross-infection has been controversial. Evidence-based guidance on ventilator-acquired pneumonia (VAP) 4 suggests that ventilator circuits should not be changed routinely for infection control purposes on an individual patient and that passive humidification may be less efficient than active methods. In these high-flow circuits, water bath humidifiers are generally used to provide efficient humidification. The use of in-line HME viral filters would preclude the use of water bath humidifiers. Respironics Inc. recommends that where a humidifier is required, a heated water bath type should be used.
The recent SARS outbreaks have highlighted the risks to healthcare workers of cross-infection by airborne droplet transmission. 5 The Hong Kong Lung Foundation reported NIV use with viral filters in 20 SARS patients; 102 healthcare workers involved in caring for these patients who consented to blood serology were negative for coronavirus. 6 However, these patients were all nursed in isolation rooms with negative pressure ventilation and all staff wore full protective clothing and in some cases a 3M ™ Air-Mate HEPA powered air purifying respirator system.
With the spectre of avian influenza, and now 'swine flu', as well as other infections transmissible by droplets, it makes sense to minimise the risk to other patients and healthcare workers. It is difficult to quantify the extent of the risk, but if we have cultured MRSA from the expired gases from an unprotected expiratory orifice, it is likely that other pathogens can be spread in this manner, and healthcare Trusts have a duty to protect other patients and staff. Department of Health guidelines 7 for treatment of pandemic influenza state that: 'NIV may be of value as a bridge to invasive ventilation in specific circumstances. In all instances, the risk of infection due to the dissemination of respiratory droplets related to the use of NIV must be taken into account when deciding on management strategies' and go on to advise that these patients should be in critical care units using full infection control measures and personal protection equipment.
Newer invasive ventilators now have the ability to provide NIV through closed circuits, but these ventilators are expensive, and only suitable for use in level 3 intensive care units. NIV with open circuits, on the other hand, is now routinely used in accident and emergency departments, medical admission wards and respiratory wards long before a specific diagnosis has been made and the infectivity of the patient can be determined.
There was little difference in the minute volumes delivered by the ventilator using the original and modified orifice at the three different EPAP levels. In all but a few readings there was a slight reduction in minute volume using the modified orifice. These are small differences in minute volume, and the ventilators are set to ventilate to a preset pressure rather than a volume, to counteract the various leaks in the system, which at higher pressures may be quite large. There are often large breath-to-breath differences of several hundred millilitres, in patients on NIV, which makes these differences of up to 250 millilitres per minute clinically irrelevant. The small difference between the devices may be due either to a slight difference in diameter of the orifices, or the thickness of material used for the orifice.
Discussions are underway with manufacturers of these circuits, and it is hoped that the device will be manufactured and formally tested in circuits designed to fit presently available NIV ventilators. It would be easy to incorporate it into a more standard two-limb circuit, or even a coaxial circuit. When commercially available it may be possible not only to determine the risk of transmission of droplet-borne infections by NIV, but also routinely to reduce this risk.
